Citation 121638

LATHA,MS: VIJAYAMMAL,PL: KURUP,PA:. (1993). EFFECT OF NICOTINE ADMINISTRATION ON LIPID METABOLISM IN RATS.. 98(1)

Citation Details

Title	EFFECT OF NICOTINE ADMINISTRATION ON LIPID METABOLISM IN RATS.
Authors	LATHA,MS: VIJAYAMMAL,PL: KURUP,PA:
Year	1993
Volume	98
Issue	1

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	WEIGHT LOSS	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
2	CHOLESTEROL LEVEL INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
3	CHOLESTEROL LEVEL INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
4	CHOLESTEROL LEVEL INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
5	CHOLESTEROL LEVEL INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
6	CHOLESTEROL LEVEL INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
7	CHOLESTEROL LEVEL INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
8	HYPERTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
9	HYPERTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
10	HYPERTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
11	HYPERTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
12	HYPERTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
13	HYPERTRIGLYCERIDEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
14	FATTY ACID CONTENT INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
15	FATTY ACID CONTENT INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
16	FATTY ACID CONTENT INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
17	FATTY ACID CONTENT INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
18	FATTY ACID CONTENT INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	INACTIVE
19	CHOLESTEROL SYNTHESIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
20	CHOLESTEROL SYNTHESIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
21	HMG-CO-A REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
22	CHOLESTEROL SYNTHESIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
23	HMG-CO-A REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
24	CHOLESTEROL SYNTHESIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
25	HMG-CO-A REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
26	LIPOPROTEIN LIPASE INHIBITION(ADIPOSE)	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
27	MALIC ENZYME STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
28	MALIC ENZYME STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
29	GLUCOSE-6-PHOSPHATE DEHYDROGENASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE
30	GLUCOSE-6-PHOSPHATE DEHYDROGENASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NICOTINE	ACTIVE

Citation 121638

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1